Expert Review of Molecular Diagnostics (ISSN 1473-7159) publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting.
Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations featuring assessments of significant, recently published articles from specialists in molecular diagnostic therapy.
Expert Review of Molecular Diagnostics provides the forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community.
Key areas of coverage include:
• Contemporary genetic and genomic technologies including deep sequencing and genome-wide association studies
• Molecular tools for infectious disease testing and detection of multiply-resistant bacteria
• Latest discoveries in oncology diagnostics
• Progress in non-invasive prenatal testing, including molecular markers and ethical considerations
• 'Omic’ diagnostic technologies including: pharmacogenomic, epigenomic, proteomic and metabolomic technologies
• Disease predisposition and inherited genetic diseases testing
• Diagnostic tests for point-of-care settings and for resource-limited settings
• Progress in developing handheld devices for molecular diagnostic tests
• Biomarker development and usage to target patient groups for personalized medicine
• Tools for molecular prognosis
• Novel technologies and developments in molecular diagnostic techniques
• Regulatory, ethical and payor perspectives in molecular diagnostics

Editor-in-Chief
Attila T Lorincz, Queen Mary University of London, UK 

Associate Editors 
William C S Cho, Queen Elizabeth Hospital, Hong Kong 
Samir Hanash, Fred Hutchinson Cancer Research Center, WA, USA 
Tim Harris, Biogen Idec, MA, USA 
George Poste, Arizona State University, AZ, USA 
Jeffrey S Ross, Albany Medical College, NY, USA

Editorial Board Members
Blair E, Integrated Medicines Ltd, Cambridge, UK
Borrebaeck C, Lund University, Lund, Sweden
Borry P, Katholieke Universiteit Leuven, Leuven, Belgium
Calin GA, University of Texas: MD Anderson Cancer Center, TX, USA
Cantor CR, Agena Bioscience, San Diego, CA, USA
Hardiman G, Medical University of South Carolina, SC, USA
Ichiishi E, International University of Health and Welfare Hospital, Nasushiobara City, Japan
Jiang S-W, Mercer University, GA, USA
Kelley SO, University of Toronto, Toronto, Canada
Klein R, Cleveland Clinic, OH, USA
Liotta LA, George Mason University, VA, USA
Ogino S, Dana-Farber Cancer Institute, MA, USA
Pai M, McGill University, Montreal, Canada
Pritzker KH, RNA Diagnostics Inc., Toronto, Canada
Salto-Tellez M, Queen’s University Belfast, Belfast, UK
Povoski SP, Ohio State University, OH, USA
Wojdacz TK, University of Aarhus, Aarhus, Denmark
Trøst Jørgensen J, Dx-Rx Institute, Fredensborg, Denmark 
Pai N, McGill University, Montreal, Canada 
Van Der Pol B, University of Alabama at Birmingham School of Medicine, AL, USA 
Rolain JM, Aix-Marseille Université, Marseille, France 
Franciotta D, C. Mondino National Neurological Institute, Pavia, Italy 
McCarthy MW, Cornell University, NY, USA 
Chan KCA, The Chinese University of Hong Kong, Hong Kong SAR, China 
Schittenhelm J, Eberhard Karls University Tuebingen, Tuebingen, Germany